1.ISPAD Consensus Guidelines for the management of type 1 Diabetes Mellitus in children 2000. Norway: Medical Forum International; 2000. 2.Altomare E, Grattagliano I, Vendemaile G, Micelli-Ferrari T, Signorile A. (1997): Oxidative protein damage in human diabetic eye: evidence of a retinal participation. Eur. J. Clin. Invest 1997; 27: 141-47. 3. Schliecher E D, Wagner E, Nerlich A G. Increased accumulation of the glycoxidation product N (carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest 1997; 99: 457-68. 4.West I C. Radicals and oxidative stress in diabetes. British Diabetic Association. Diabetic Medicine 2000; 17: 171-80. 5.Aruoma O I, Hallinuell B, Hoeny B M, Butler J. The antioxidant action of N-acetylcysteine: Its reaction with H2O2, •OH, O2•- and HOCl. Free Radic. Biol. Med 1989; 6: 593-97. 6. Ceriello A. Acute hyperglycemia and oxidative stress generation. Diabet. Med 1997; 14 (suppl. 3):S45-S49. 7. Rösen P, Nawroth P P, King G, Möller W, Tritscheler H J, Packer L.The Role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO- MCBN, the American Diabetes Association and the German Diabetes Society. Diabet. Metabolism Res. Rev 2001; 17: 189-212. 8. Momposo M, León OS, Licea ME, Pérez B, Castillo R. Especies reactivas de oxígeno en la diabetes mellitus con retinopatía diabética y sin ella. Rev. Cubana de Endocrinología 1999; 10: 8-15. 9.Sánchez GM, Re L, Giuliani A, Núñez AJ, Davison GP, León OS. Protective effects Mangifera indica L. extract mangiferin and selected antioxidants against TPA – Induced biomolecules oxidation and peritoneal macrophage activation in mice. Pharmacological Research 2000; 42:565-71. 10. Martínez G, Delgado R, Pérez G, Garrido G, Núñez – Sellés AJ, León OS. Evaluation of the in vitro antioxidant activity of Mangifera indica L. extracts (QF – 808). Phytotherapy Research 2000; 14:424-27. 11. Núñez AJ. Vimang® nueva línea de productos naturales. Avances médicos de Cuba 1999;6:37-40. 12. Martínez G, Giuliani A, León OS, Pérez G, Núñez AJ. Effect of Mangifera Indica L. extract (VIMANG®) on proteins and hepatic microsomes peroxidation . Phytotherapy Research 2001; 25 : 581 – 85 . 13. Martínez G, Rodrigez MA, Nuñez AJ, Pons N, Sam S, León OS. Protective Effect of Mangifera Indica L. extract (VIMANG®) on the injury associated to hepatic ischemia reperfusion . Pharmacological Research 2001; 42: 565 – 73. 14. Martínez G, Re L, Nuñez AJ, Davison GP, León OS. Protective Effect of Mangifera Indica L. extracts mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice. Pharmacological Research 2001; 42:565 – 73. 15.Martínez G, Candelario E, Giuliani A, León OS, Sam S, Delgado R et al. Mangifera Indica L. Extract (VIMANG® ) reduces ischecmia – induced neuronal loss and oxidative damage in the gerbil brain. Free Radical Res. 2001; 35: 465-73. 16. Núñez SA, Páez BE, Amaro GD, Acosta EJ, Agüero AJ, Capote HR y col. Composiciones farmacéuticas y suplementos nutricionales a partir de extractos de Mangifera indica. L. Patente con Certificado No: 22846 OCPI 2002. 17. Nuñez Sellés, AJ Vélez, H Agüero, J González, J Naddeo, F, De Simone, F, Rastrelli, L. “Isolation and quantitative análisis of phenolic antioxidants, free sugars, and polyols from mango (Mangifera indica L.) bark aqueos decoction used in Cuba as nutricional supplement”. (2002) J Agric Food Chem 50: 762-766. 17.García D, Delgado R, Ubeira F.M, Leiro J. Modulator efects of rat macrophage function by Mangifera indica L extract (Vimang) and mangiferin. International Immunopharmacology 2 (6): 797-806, 2002. 18.Gámez R, Mas R, Arruzazabala M, Noa M. Estudios de toxicidad por dosis únicas del Vimang en roedores: Ratas Sprague Dawley y ratones OF-1. Reporte Final de estudios toxicológicos. CQF. 2001; 6-38. 19. Gámez R, Mas R, Arruzazabala M, Noa M. Estudio de la toxicidad subcrónica oral (Estudio de los 90 días) del Vimang® en ratas Sprague Dawley. Reporte Final de estudio toxicológico. CQF. 2002; 8-39. 20. Miura T, Iwamoto N, Kato M, Ichiki H, Kubo M, Komatsu Y, Ishida T, Okada M, Tanigawa K. The suppressive effect of mangiferin with exercise on blood lipids in type 2 diabetes. Biol Pharm Bull 2001 Sep;24(9):1091-2 21. Miura T, Ichiki H, Iwamoto N, Kato M, Kubo M, Sasaki H, Okada M, Ishida T, Seino Y, Tanigawa K. Antidiabetic activity of the rhizoma of Anemarrhena asphodeloides and active components, mangiferin and its glucoside. Biol Pharm Bull 2001 Sep;24(9):1009-11. 22. Miura T, Ichiki H, Hashimoto I, Iwamoto N, Kato M, Kubo M, Ishihara E, Komatsu Y, Okada M, Ishida T, Tanigawa K. Antidiabetic activity of a xanthone compound, mangiferin. Phytomedicine 2001 Mar;8(2):85-7.40. 23.Yoshikawa M, Nishida N, Shimoda H, Takada M, Kawahara Y, Matsuda H. [Polyphenol constituents from Salacia species: quantitative analysis of mangiferin with alpha-glucosidase and aldose reductase inhibitory activities] Yakugaku Zasshi 2001 May;121(5):371-8. 24. Ichiki H, Miura T, Kubo M, Ishihara E, Komatsu Y, Tanigawa K, Okada M. New antidiabetic compounds, mangiferin and its glucoside. Biol Pharm Bull 1998 Dec;21(12):1389-90. 25. Yoshikawa M, Nishida N, Shimoda H, Takada M, Kawahara Y, Matsuda H. [Polyphenol constituents from Salacia species: quantitative analysis of mangiferin with alpha-glucosidase and aldose reductase inhibitory activities] Yakugaku Zasshi 2001 May;121(5):371-8.
